Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vironexis Clinical Trials
Vironexis Biotherapeutics Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
Anthony Stein, MDRecruiting - Valkyrie Clinical Trials
Los Angeles, California, United States
Recruiting - Colorado Blood Cancer Institute
Denver, Colorado, United States
Recruiting - New York Medical College
Valhalla, New York, United States
Mitchell Cairo, MDRecruiting - University of North Carolina at Chapel Hill/ University of North Carolina Medical Center
Chapel Hill, North Carolina, United States
Recruiting - the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Recruiting - Oregon Health & Science University
Portland, Oregon, United States
Recruiting - Tristar Bmt
Nashville, Tennessee, United States
Recruiting - University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 2025
- Primary completion
- 30 Jun 2027
- Completion
- 30 Sept 2031
- Last update posted
- 30 Mar 2026
- Registered enrollment
- 32
- Registry id
- NCT06533579
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.